The Ultimate Resource for Pharmaceutical SOPs and Best Practices
This SOP provides the procedure for auditing third-party manufacturers of tablets to ensure compliance with GMP, regulatory guidelines, and company quality standards. It aims to assess manufacturing practices, quality control procedures, and documentation practices to ensure tablet products are safe, effective, and manufactured to required specifications.
Click to read the full article.
The purpose of this SOP is to define the process for the final release of tablet batches, ensuring that all batches meet the required quality standards and comply with regulatory guidelines before they are authorized for distribution and sale.
Click to read the full article.
This SOP outlines the procedure for implementing risk-based monitoring during tablet manufacturing processes. The goal is to focus resources on critical process parameters (CPPs) and critical quality attributes (CQAs) to mitigate risks that could impact product quality, compliance, and patient safety.
Click to read the full article.
The purpose of this SOP is to outline the procedure for identifying, investigating, and implementing Corrective and Preventive Actions (CAPA) to address deviations, non-conformances, or any issues within the tablet manufacturing process. The goal is to prevent recurrence and improve the overall quality management system.
Click to read the full article.
This SOP defines the procedures for identifying, handling, and resolving non-conforming products during the tablet manufacturing process. Its goal is to ensure that non-conforming products are properly managed to prevent their distribution and to improve overall product quality.
Click to read the full article.
This SOP defines the procedures for the proper storage and handling of rejected materials during tablet manufacturing. Its goal is to ensure rejected materials are clearly segregated, handled safely, and disposed of according to regulatory requirements to maintain product quality and safety.
Click to read the full article.
The purpose of this SOP is to define the process for establishing Critical Quality Attributes (CQAs) for tablet products. The goal is to ensure that CQAs are identified early in the product development process and are monitored throughout manufacturing to guarantee product quality and compliance with regulatory standards.
Click to read the full article.
This SOP defines the procedure for reviewing blending and granulation records to ensure that the processes are carried out according to established specifications, regulatory requirements, and internal quality standards. The goal is to verify the consistency and quality of tablet batches.
Click to read the full article.
This SOP outlines the process for conducting risk assessments for new tablet products. The goal is to identify and mitigate potential risks to product quality, safety, and regulatory compliance during the development and manufacturing processes.
Click to read the full article.
The purpose of this SOP is to establish the procedures for ensuring that Quality Assurance (QA) is involved in equipment qualification throughout the tablet manufacturing process. This ensures that equipment operates within the required specifications and meets both regulatory and internal quality standards.
Click to read the full article.
Don’t leave empty-handed. Watch practical GMP scenarios, inspection lessons, deviations, CAPA thinking, and real compliance insights on our YouTube channel. One click now can save you hours later.